The hard part is already done: the expensive phase of a major undertaking is finished, and the company is now in the col
The model's full reasoning — Q4 2015 call → NOWe need answer YES or NO. Need evaluate transcript. Question: Does management convey recently finished expensive/uncertain/heavy phase of major undertaking and entered collecting phase, with reported results still reflecting paying phase not collecting? Need identify major undertaking. Possible candidates: distribution center expansion/modernization, consumer fulfillment initiative, new brands (George Brown, Diane von Furstenberg), Sam Edelman retail stores, supply chain initiative, rebranding, etc. Need see if management describes heavy phase substantially done and benefits beginning but not yet in numbers. Let's parse. Diane: "We also committed to investing in our future with the expansion and modernization of our distribution centers, the launch of two new brands, the continued expansion of our Sam Edelman brand and his retail stores, our consumer targeting efforts at Famous Footwear and our continued investment in digital across the enterprise." "In 2016, you can expect more of the same from us as we invest in our brands and our infrastructure and our people." That suggests ongoing investments. Ken guidance: "This guidance includes the opening of 55 new Famous Footwear stores and the closing of approximately 40 stores. The opening of 6 new Sam Edelman retail stores and the addition to the 6 we’re already operating at year-end, the continued expansion and modernization of our distribution centers and the ramp-up of our 2 new Contemporary Fashion brands George Brown and Diane von Furstenberg." So still expansion/ramp-up. Question asks: "recently FINISHED THE EXPENSIVE, UNCERTAIN, OR HEAVY PHASE OF A MAJOR UNDERTAKING — the part that consumed money, time, and organizational energy — and has now entered the phase where the company COLLECTS on that completed work" There is no indication that heavy phase is done. They are still investing in DCs, still opening stores, ramping up brands. They mention supply chain initiative "we'd expect that -- I would think some time in the middle of this year, most of that work will be really well underway and our expectations are that in 2017 we should have some material impact from that work" So still underway, benefits future. Also "continued expansion and modernization of distribution centers" not finished. They did rebrand company, but no mention of collecting from that.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| HUYA | HUYA Inc. | Q4 2023 | 2024-03-19 | C |
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| DAL | Delta Air Lines, Inc. | Q2 2023 | 2023-07-13 | A |
| CURV | Torrid Holdings Inc. | Q2 2022 | 2022-09-07 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| LPTH | LightPath Technologies, Inc. | Q4 2021 | 2021-09-09 | D |
| WES | Western Midstream Partners, LP | Q3 2018 | 2018-10-31 | D |
| HTLF | Heartland Financial USA, Inc. | Q3 2017 | 2017-10-30 | B+ |
| IBTX | Independent Bank Group, Inc. | Q3 2017 | 2017-10-24 | A |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| ARCB | ArcBest Corporation | Q4 2016 | 2017-02-08 | C |
IONS · Q1 2017 → YESThe question is about whether management conveys that the company has recently finished the expensive, uncertain, or heavy phase of a major undertaking and has now entered the collecting phase, with r...YES Management describes the heavy phase of the SPINRAZA program as concluded ("we concluded our costly Phase III program"), with R&D expenses now expected to decline as the company transitions to a multiproduct profitable organization. They note that Q1 marked the first full quarter of commercial revenues ($47 million), with royalties of 5.2 million reflecting the early stage of this new revenue stream, while the reported results still include substantial R&D revenue (102 million) and show profitability driven by the ongoing evolution toward sustained profitability. The commercial benefits are visibly beginning but remain early, with the numbers carrying the burden of the prior development effort.
PKOH · Q3 2022 → YESThe question is about whether management conveys that the company has recently finished the expensive, uncertain, or heavy phase of a major undertaking and has now entered the phase where they collect...YES Management describes the restructuring of 14 global locations as "largely completed," with the cycle finished and no significant customer attrition. They are now pivoting to focus on the balance sheet and "harvesting some of the significant cash investments" made over the last couple of years, while noting that earnings are continuing to improve sequentially in Q4 despite inflation. The reported results show positive cash flow and improved metrics, but the harvest is described as beginning, with the $60 million working capital investment expected to convert over 12-18 months, indicating the collecting phase is early and the numbers still largely reflect the prior paying phase.
AKYA · Q2 2023 → YESThe question is about whether management conveys that the company has recently finished the expensive, uncertain, or heavy phase of a major undertaking and has now entered the collecting phase, with r...YES Management describes the first phase (2021–end of 2022) as having completed its core objectives: successful launch of Fusion, portfolio development, organizational expansion, and platform enhancements. They explicitly frame the second phase as now beginning, with the reported Q2 results still carrying the burden of that prior heavy investment (high OpEx, RIF charges, gross-margin pressure) while the new phase is visibly starting to deliver through record revenue, reagent pull-through, and cost-optimization moves. The numbers lag the crossing, as the company is still pre-profitability and targeting cash-flow positivity only in 2025.